person · Reporting owner

Boehnlein Glenn S

Disclosed activity across 4 companies

Tapewire entity: 15116
SEC CIK: 0001670936

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
AGILENT TECHNOLOGIES, INC.A · Entity 3062	Director	September 08, 2026	September 10, 2026
DEXCOM INCDXCM · Entity 3114	Director	September 10, 2026	September 10, 2026
Inogen IncINGN · Entity 2083	Director	June 05, 2026	June 09, 2026
STRYKER CORPSYK · Entity 369	VP, Chief Financial Officer	March 21, 2025	March 25, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AGILENT TECHNOLOGIES, INC.

Report date September 08, 2026 · Filed September 10, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	817	Reported balance After 2026-09-08 transaction · row 1 1 source row Row 1 · 2026-09-08 · Grant · Acquired 817 · Balance 817 F1: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant.
Common StockSEC Table I · non-derivative	IndirectBoehnlein 2017 Trust	35	Reported balance Holding disclosure · report date 2026-09-08 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 35 F2: Shares held by the Boehnlein 2017 Trust for which Glenn and Susan Boehnlein are the trustees.

Filing footnotes · ownership attribution and instrument terms

F1: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant.

F2: Shares held by the Boehnlein 2017 Trust for which Glenn and Susan Boehnlein are the trustees.

DEXCOM INC

Report date September 10, 2026 · Filed September 10, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	5,841	Reported balance After 2026-09-10 transaction · row 1 1 source row Row 1 · 2026-09-10 · Grant · Acquired 5,841 · Balance 5,841 F1: Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
Common StockSEC Table I · non-derivative	IndirectBy Trust	42	Reported balance Holding disclosure · report date 2026-09-10 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 42 F2: Shares are held by the Boehnlein 2017 Trust, with respect to which the Reporting Person and the Reporting Person's spouse are co-trustees.

Filing footnotes · ownership attribution and instrument terms

F1: Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2: Shares are held by the Boehnlein 2017 Trust, with respect to which the Reporting Person and the Reporting Person's spouse are co-trustees.

Inogen Inc

Report date June 05, 2026 · Filed June 09, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	104,966	Reported balance After 2026-06-05 transaction · row 1 1 source row Row 1 · 2026-06-05 · Grant · Acquired 28,081 · Balance 104,966 F1: The reported shares were acquired pursuant to a restricted stock unit award. Subject to the reporting person's continued service, the restricted stock unit award shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant.

Filing footnotes · ownership attribution and instrument terms

F1: The reported shares were acquired pursuant to a restricted stock unit award. Subject to the reporting person's continued service, the restricted stock unit award shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant.

STRYKER CORP

Report date March 21, 2025 · Filed March 25, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	11,638	Ending reported balance After 2025-03-21 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2025-03-21 · Exercise / conversion · Acquired 314 · Balance 18,358 F1: On March 12, 2025, the Reporting Person filed a Form 4 reporting the acquisition of 12,916 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2025 (the "Performance Stock Units"). The 314 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2025 and were settled for an equal number of shares of Stryker Common Stock. Row 2 · 2025-03-21 · Tax withholding · Disposed 6,720 · Balance 11,638
Dividend EquivalentsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2025-03-21 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2025-03-21 · Exercise / conversion · Disposed 314 · Balance 0 F1: On March 12, 2025, the Reporting Person filed a Form 4 reporting the acquisition of 12,916 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2025 (the "Performance Stock Units"). The 314 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2025 and were settled for an equal number of shares of Stryker Common Stock.
Common StockSEC Table I · non-derivative	IndirectBy 401K	1,557	Reported balance Holding disclosure · report date 2025-03-21 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 1,557

Filing footnotes · ownership attribution and instrument terms

F1: On March 12, 2025, the Reporting Person filed a Form 4 reporting the acquisition of 12,916 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2025 (the "Performance Stock Units"). The 314 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2025 and were settled for an equal number of shares of Stryker Common Stock.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
February 07, 2018 Filed Feb 9, 2018 02:51 UTC	STRYKER CORP SYK · Entity 369	GrantEmployee Stock Option granted 2/7/2018 (right to buy) · Derivative	38,925	$0.00 Strike: $154.14	$0.00	Disclosure SEC source: 0000310764-18-000034 · edgar.xml · derivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,925 Underlying: Common Stock · 38,925 shares Expires 2028-02-06 F1 · derivative.exercise_date: Employee stock option granted purusant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document
March 21, 2017 Filed Mar 23, 2017 21:13 UTC	STRYKER CORP SYK · Entity 369	Exercise / conversionRestricted Stock Units granted 02-11-2015 · Derivative	904	Not disclosed	Not disclosed	Disclosure SEC source: 0000310764-17-000078 · edgar.xml · derivative · entry 7 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 904 Underlying: Common Stock · 904 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: On March 21, 2017, 904 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F2 · price: On March 21, 2017, 904 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest as to 904 shares on March 21, 2018. F3 · derivative.expiration_date: The Restricted Stock Units vest as to 904 shares on March 21, 2018. Read SEC document
March 21, 2017 Filed Mar 23, 2017 21:13 UTC	STRYKER CORP SYK · Entity 369	Exercise / conversionRestricted Stock Units granted 02-12-2014 · Derivative	996	Not disclosed	Not disclosed	Disclosure SEC source: 0000310764-17-000078 · edgar.xml · derivative · entry 6 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 996 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 21, 2017, 996 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · price: On March 21, 2017, 996 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.exercise_date: On March 21, 2017, 996 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.expiration_date: On March 21, 2017, 996 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document
March 21, 2017 Filed Mar 23, 2017 21:13 UTC	STRYKER CORP SYK · Entity 369	Tax withholdingCommon Stock	340	$132.59	$45,080.60	Disclosure SEC source: 0000310764-17-000078 · edgar.xml · nonDerivative · entry 4 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,694 Read SEC document
March 21, 2017 Filed Mar 23, 2017 21:13 UTC	STRYKER CORP SYK · Entity 369	Exercise / conversionCommon Stock	904	$0.00	$0.00	Disclosure SEC source: 0000310764-17-000078 · edgar.xml · nonDerivative · entry 3 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: On March 21, 2017, 904 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document
March 21, 2017 Filed Mar 23, 2017 21:13 UTC	STRYKER CORP SYK · Entity 369	Tax withholdingCommon Stock	375	$132.59	$49,721.25	Disclosure SEC source: 0000310764-17-000078 · edgar.xml · nonDerivative · entry 2 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,130 Read SEC document
March 21, 2017 Filed Mar 23, 2017 21:13 UTC	STRYKER CORP SYK · Entity 369	Exercise / conversionCommon Stock	996	$0.00	$0.00	Disclosure SEC source: 0000310764-17-000078 · edgar.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On March 21, 2017, 996 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document
February 08, 2017 Filed Feb 10, 2017 21:26 UTC	STRYKER CORP SYK · Entity 369	GrantEmployee Stock Option granted 2/8/2017 (right to buy) · Derivative	40,815	$122.51 Strike: $122.51	$5,000,245.65	Disclosure SEC source: 0000310764-17-000041 · wf-form4_148676199463091.xml · derivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,815 Underlying: Common Stock · 40,815 shares Expires 2027-02-07 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document
April 27, 2016 Filed Apr 29, 2016 15:42 UTC	STRYKER CORP SYK · Entity 369	SaleCommon Stock	2,000	$109.61	$219,228.00	Disclosure SEC source: 0000310764-16-000332 · wf-form4_146194456487224.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · VP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,509 Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.